The authors investigated the effect of ketanserin 0.5% eye drops on intraoc
ular pressure and orbital blood flow in some healthy volunteers. Ketanserin
is a selective antagonist of serotonin S-2 receptors; moreover, it produce
s an alpha(1)-blocking effect. it causes a systemic reduction of blood pres
sure and capillary vasodilatation. Three hours after topical administration
of ketanserin 0.5%, the intraocular pressure was decreased by about 14% fr
om the baseline. At the same time, we observed by color Doppler imaging tha
t the mean percent increase in the peak systolic velocity in the ophthalmic
artery (OA) was 5.18% (p < 0.161) and 23.18% (p < 0.001) in the posterior
ciliary arteries (PCAs). The mean resistance index of the OA was in contras
t reduced by 1.16% (p < 0.669) and by 32.14% (p < 0.003) in the PCAs. These
data show that ketanserin 0.5% eye drops may be useful not only to decreas
e intraocular pressure but also to improve blood flow in the PCAs that supp
ly the optic nerve head.